News und Analysen
Stellantis Makes a High-Stakes Bet on Jeep
Stellantis (NYSE: STLA) experienced a significant turnaround in the third quarter of 2025, rebounding from a challenging first half of the year that resulted in a net loss. This sharp reversal
Altimmune Aktie: MASH-Durchbruch!
Die Altimmune-Aktie erlebt einen deutlichen Aufschwung nach der Veröffentlichung bahnbrechender klinischer Daten für ihre…
Der Beitrag Altimmune Aktie: MASH-Durchbruch! erschien zuerst auf kapitalma
Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
Whether buoyed by massive gains in the AI space or not, the S&P 500 has experienced a strong several months, climbing by nearly 33% since early April. Two fairly under-appreciated companies—
S&P 500, XLK und Marktbewegungen im April 2025
Monument schließt Kooperationsvertrag ab und gewährt Odyssey Zugang zur Burnakura-Mühle
VANCOUVER, British Columbia, April 15, 2025 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY, FSE: D7Q1) („Monument“ oder das „Unternehmen“) freut sich, die Unterzeichnung einer
Die Auswirkungen der Zollerklärungen von Trump auf den Aktienmarkt
Wie Zölle den Schifffahrtssektor beeinflussen
Aktienanalyse: Die drastischen Veränderungen am Markt im Fokus
S&P 500: Prognosen zur V-förmigen Erholung der Aktien nach dem 2. April 2025 - Bedeutung und Strategien
Cassava Sciences Stock: Alzheimer Drug Fails, Program Terminated
Cassava Sciences faces a significant setback after announcing its drug Simufilam failed to achieve meaningful results in the Phase-3 REFOCUS-ALZ study involving 1,125 patients with mild to moderate
Iridex Stock: Volatility Persists Amid Stable Fundamentals
Iridex Corporation (NASDAQ: IRIX) shares experienced significant fluctuations last week, with March 13, 2025 showing particularly volatile trading patterns. The Mountain View, California-based
Celldex Therapeutics Aktie: Droht nun Stagnation?
Die Celldex Therapeutics Aktie verzeichnete am 12. März 2025 eine deutliche Erholung mit einem Plus von 4,81 Prozent auf 20,50 USD im Vergleich zum Vortag. Diese positive Entwicklung steht im
Aehr Test Stock: AI Expansion Amid Financial Challenges
Aehr Test Systems recently hit its 52-week low at $9.82, representing a significant 38% decline over the past year. Despite this market challenge, the company maintains robust fundamentals with a
Ocean Power Technologies Aktie: Positive Entwicklung sorgt für Freude
Die Aktie des Meeresenergie-Spezialisten Ocean Power Technologies verzeichnet eine positive Entwicklung an den Märkten. Der aktuelle Kurs liegt bei 0,7961 USD, was einem Tagesplus von 0,45 Prozent
Odyssey Marine Exploration Aktie: Angespannte Lage droht!
Die Aktie des Meeresressourcen-Unternehmens Odyssey Marine Exploration verzeichnet aktuell eine anhaltende Abwärtsbewegung an der Börse. Der Kurs fiel am 13. Februar 2025 um weitere 4,23 Prozent auf
FuelCell Energy Aktie: Die Situation bleibt unklar?
Die FuelCell Energy, ein führender Entwickler von Brennstoffzellen-Technologie, bereitet sich auf die Veröffentlichung der Quartalsergebnisse für das erste Quartal 2025 vor. Die Bekanntgabe der
Odyssey Marine Exploration Aktie: Das dicke Ende naht?
Die Odyssey Marine Exploration verzeichnet aktuell eine anhaltende Abwärtsbewegung an der Börse. Der Aktienkurs des auf Meeresbodenressourcen spezialisierten Unternehmens fiel am 5. Februar 2025 um
Generative AI Upside: 2 Software Stocks Could Triple Revenue in 5 Years
The artificial intelligence (AI) market has grown rapidly over the past decade. Most of its recent growth was fueled by new generative AI platforms -- such as OpenAI's ChatGPT and Alphabet's Google
Why Innodata Stock Lost 23% in November
Shares of Innodata (NASDAQ: INOD), an AI stock focused on data-labeling, were pulling back last month as the stock reacted to concerns about the AI bubble bursting and an underwhelming earnings
This Growth Stock Continues to Crush the Market
Here's a bit of a flashback for you. Innodata's (NASDAQ: INOD) stock price more than doubled in November 2024, thanks to a fantastic earnings report.
Innodata's gains didn't stop there, though. The
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer
On November 14, 2025, Bain Capital Life Sciences Investors, LLC disclosed a purchase of 520,310 shares of Cidara Therapeutics (NASDAQ:CDTX), increasing its position value by approximately $167.48
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.
Just prior to last week's takeover news, Cidara Therapeutics (NASDAQ: CDTX) was already one of the year's top-performing stocks. Trading in the mid-$20s at the start of 2025, by mid-November, this
This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover
California-based TCG Crossover Management fully exited its position in Cidara Therapeutics (NASDAQ:CDTX) during the third quarter, reducing its holdings by 1 million shares in a move valued at
Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term.
It might seem like a risky time to buy stocks. The S&P 500 is hovering near its all-time high and looks historically expensive at 30 times earnings, while the closely watched Treasury yields remain
1 Tech Stock to Buy Before the End of 2025
Artificial intelligence (AI) is driving growing demand for two incredibly important assets: data center capacity and access to quality data to train the AI. Innodata (NASDAQ: INOD) is a small